Market Closed -
Australian S.E.
02:10:22 2024-05-23 am EDT
|
5-day change
|
1st Jan Change
|
1.155
AUD
|
+0.87%
|
|
-2.12%
|
-21.43%
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
447.4
|
740.1
|
648.8
|
-
|
-
|
Enterprise Value (EV)
1 |
467
|
1,436
|
1,098
|
1,111
|
1,130
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
Yield
|
5.45%
|
5.8%
|
7.01%
|
7.2%
|
7.72%
|
Capitalization / Revenue
|
15.4
x
|
15.5
x
|
9.85
x
|
9.56
x
|
9.14
x
|
EV / Revenue
|
16
x
|
30.1
x
|
16.7
x
|
16.4
x
|
15.9
x
|
EV / EBITDA
|
24.5
x
|
48.5
x
|
18
x
|
17.7
x
|
17
x
|
EV / FCF
|
19.8
x
|
63.3
x
|
50.8
x
|
37.2
x
|
20.7
x
|
FCF Yield
|
5.05%
|
1.58%
|
1.97%
|
2.69%
|
4.83%
|
Price to Book
|
0.68
x
|
0.78
x
|
0.68
x
|
0.66
x
|
0.65
x
|
Nbr of stocks (in thousands)
|
325,378
|
562,814
|
566,673
|
-
|
-
|
Reference price
2 |
1.375
|
1.315
|
1.145
|
1.145
|
1.145
|
Announcement Date
|
8/11/22
|
8/14/23
|
-
|
-
|
-
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
29.14
|
47.7
|
65.89
|
67.9
|
71
|
EBITDA
1 |
19.1
|
29.6
|
61.15
|
62.81
|
66.53
|
EBIT
1 |
17.47
|
29.6
|
62.34
|
64.96
|
67.91
|
Operating Margin
|
59.94%
|
62.05%
|
94.61%
|
95.66%
|
95.65%
|
Earnings before Tax (EBT)
|
49.61
|
-
|
-
|
-
|
-
|
Net income
|
-
|
20.2
|
-
|
-
|
-
|
Net margin
|
-
|
42.35%
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
23.59
|
22.7
|
21.6
|
29.9
|
54.6
|
FCF margin
|
80.95%
|
47.59%
|
32.78%
|
44.04%
|
76.9%
|
FCF Conversion (EBITDA)
|
123.49%
|
76.69%
|
35.32%
|
47.6%
|
82.07%
|
FCF Conversion (Net income)
|
-
|
112.38%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.0750
|
0.0762
|
0.0802
|
0.0824
|
0.0883
|
Announcement Date
|
8/11/22
|
8/14/23
|
-
|
-
|
-
|
Fiscal Period: June |
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
---|
Net sales
1 |
10.84
|
18.29
|
-
|
-
|
39.6
|
EBITDA
1 |
-
|
-
|
-
|
18.4
|
29.1
|
EBIT
1 |
4.423
|
11.39
|
10.6
|
18.4
|
29.1
|
Operating Margin
|
40.79%
|
62.25%
|
-
|
-
|
73.48%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
1.542
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
0.004700
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.0388
|
-
|
Announcement Date
|
2/17/22
|
8/11/22
|
2/16/23
|
8/14/23
|
2/12/24
|
Fiscal Period: June |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
19.6
|
696
|
449
|
463
|
481
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.026
x
|
23.52
x
|
7.347
x
|
7.364
x
|
7.235
x
|
Free Cash Flow
1 |
23.6
|
22.7
|
21.6
|
29.9
|
54.6
|
ROE (net income / shareholders' equity)
|
2.42%
|
2.52%
|
4.73%
|
4.94%
|
5.16%
|
ROA (Net income/ Total Assets)
|
-
|
1.67%
|
2.44%
|
3.11%
|
3.86%
|
Assets
|
-
|
1,209
|
-
|
-
|
-
|
Book Value Per Share
2 |
2.010
|
1.690
|
1.700
|
1.730
|
1.760
|
Cash Flow per Share
2 |
0.0700
|
0.0600
|
0.0400
|
0.0700
|
0.0800
|
Capex
1 |
-
|
-
|
-
|
1
|
2
|
Capex / Sales
|
-
|
-
|
-
|
1.47%
|
2.82%
|
Announcement Date
|
8/11/22
|
8/14/23
|
-
|
-
|
-
|
Last Close Price
1.145
AUD Average target price
1.492
AUD Spread / Average Target +30.32% Consensus |
1st Jan change
|
Capi.
|
---|
| -21.43% | 431M | | +12.98% | 60.91B | | -2.75% | 19.58B | | -1.41% | 13.74B | | +4.11% | 7.89B | | -7.31% | 5.99B | | +13.81% | 3.62B | | +0.35% | 3.32B | | -6.36% | 3.13B | | +0.81% | 2.97B |
Healthcare REITs
|